ArticleExperimental and therapeutic medicine2012

Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab.

Jidong Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.